Literature DB >> 29882426

3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.

Rashad Al-Salahi1, Rohaya Ahmad2, ElHassane Anouar3, Nor Izzati Iwana Nor Azman2, Mohamed Marzouk3,4, Hatem A Abuelizz1.   

Abstract

AIM: Using a simple modification on a previously reported synthetic route, 3-benzyl(phenethyl)-2-thioxobenzo[g]quinazolin-4(3H)-ones (1 and 2) were synthesized with high yields. Further transformation of 1 and 2 produced derivatives 3-26, which were structurally characterized based on NMR and MS data, and their in vitro α-glucosidase inhibitory activity was evaluated using Baker's yeast α-glucosidase enzyme.
RESULTS: Compounds 2, 4, 8, 12 and 20 exhibited the highest activity (IC50 = 69.20, 59.60, 49.40, 50.20 and 83.20 μM, respectively) compared with the standard acarbose (IC50 = 143.54 μM).
CONCLUSION: A new class of potent α-glucosidase inhibitors was identified, and the molecular docking predicted plausible binding interaction of the targets in the binding pocket of α-glucosidase and rationalized the structure-activity relationship (SARs) of the target compounds.

Entities:  

Keywords:  antidiabetic; benzoquinazoline; molecular docking; α-glucosidase

Mesh:

Substances:

Year:  2018        PMID: 29882426     DOI: 10.4155/fmc-2018-0141

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  7 in total

1.  Synthesis and Biological Evaluation of 5-Fluoro-2-Oxindole Derivatives as Potential α-Glucosidase Inhibitors.

Authors:  Jing Lin; Qi-Ming Liang; Yuan-Na Ye; Di Xiao; Li Lu; Meng-Yue Li; Jian-Ping Li; Yu-Fei Zhang; Zhuang Xiong; Na Feng; Chen Li
Journal:  Front Chem       Date:  2022-06-23       Impact factor: 5.545

2.  Cytotoxicity, alpha-glucosidase inhibition and molecular docking studies of hydroxamic acid chromium(III) complexes.

Authors:  Latifah Robbaniyyah Hassan; El Hassane Anouar; Hadariah Bahron; Faiezah Abdullah; Amalina Mohd Tajuddin
Journal:  J Biol Inorg Chem       Date:  2020-01-23       Impact factor: 3.358

3.  Radioiodination and biodistribution of newly synthesized 3-benzyl-2-([3-methoxybenzyl]thio)benzo[g]quinazolin-4-(3H)-one in tumor bearing mice.

Authors:  Rashad Al-Salahi; Moustapha E Moustapha; Hatem A Abuelizz; Abdulrahman I Alharthi; Khalid A Alburikan; Ismail T Ibrahim; Mohamed Marzouk; Mohamed A Motaleb
Journal:  Saudi Pharm J       Date:  2018-06-06       Impact factor: 4.330

4.  Triazoloquinazolines as a new class of potent α-glucosidase inhibitors: in vitro evaluation and docking study.

Authors:  Hatem A Abuelizz; El Hassane Anouar; Rohaya Ahmad; Nor Izzati Iwana Nor Azman; Mohamed Marzouk; Rashad Al-Salahi
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

5.  Synthesis and biological evaluation of 4-(1H-1,2,4-triazol-1-yl)benzoic acid hybrids as anticancer agents.

Authors:  Hatem A Abuelizz; Hanem M Awad; Mohamed Marzouk; Fahd A Nasr; Ali S Alqahtani; Ahmed H Bakheit; Ahmed M Naglah; Rashad Al-Salahi
Journal:  RSC Adv       Date:  2019-06-17       Impact factor: 4.036

6.  Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies.

Authors:  Hatem A Abuelizz; Mohamed Marzouk; Ahmed H Bakheit; Rashad Al-Salahi
Journal:  RSC Adv       Date:  2020-09-30       Impact factor: 4.036

7.  Identification of Cyclic Sulfonamides with an N-Arylacetamide Group as α-Glucosidase and α-Amylase Inhibitors: Biological Evaluation and Molecular Modeling.

Authors:  Furqan Ahmad Saddique; Matloob Ahmad; Usman Ali Ashfaq; Muhammad Muddassar; Sadia Sultan; Magdi E A Zaki
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.